Press Release


Bioxytran Provides Corporate Update Highlighting Momentum Across Its Multi-Platform Pipeline
Jan 29, 2026 20:57 JST
Bioxytran, Inc. (OTCQB: BIXT) ("Bioxytran" or the "Company"), a clinical-stage biotechnology company developing platform technologies spanning glycovirology, hypoxia, and degenerative diseases, today issued a corporate update summarizing previously disclosed program developments and reinforcing the Company's strategic direction entering 2026.
More info..

Latest Release


More Latest Release >>